FDA/Industry Workshop September 14-16, 2005 Critical Path Initiative: What it means for pharmaceutical industry statisticians Walter Offen, Lilly Brenda.
OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP 1 OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP Are Observational Studies Any Good? David Madigan, Columbia University.